Regional News Archives - Page 80 of 190 - Journal for Clinical Studies

Current Edition

Regional News

As BioNTech raises expected COVID-19 vaccine sales to $19.6B, CEO stumps for wider booster use

Like its partner on its COVID-19 vaccine, BioNTech keeps upping its estimate for 2021 vaccine revenue. Last week, Pfizer jacked up its annual guidance on its vaccine ...

10 November 2021 Regional News BioNTech | COVID-19

Continue Reading →

Regional News

Biogen’s Aduhelm records one patient death. Is the controversial Alzheimer’s drug to blame?

Doctors already have reservations about Biogen’s controversial Alzheimer’s disease drug, Aduhelm. Now a reported death will likely trigger more doubts around its use....

10 November 2021 Regional News Aduhelm | Alzheimer

Continue Reading →

Regional News

Emmes launches Orphan Reach™: Emmes’ Rare Disease Center

The New Global Rare Disease Center of Emmes Expects Accelerating Growth from US and European Biotechs 03rd November, 2021, Rockville, Maryland (USA): Emmes – a full ...

4 November 2021 Regional News biotech | clinical research organisation

Continue Reading →

Regional News

Pfizer’s COVID vaccine for younger kids meets FDA bar, with CDC panel next week being key to wide rollout

Kids ages 5-11 in the United States are now eligible for vaccination against COVID-19. On Friday afternoon, the FDA authorized the Pfizer-BioNTech mRNA vaccine, Comir...

2 November 2021 Regional News clinical trial | COVID-19

Continue Reading →

Regional News

Novartis keeps the leukemia innovation coming with FDA approval for Gleevec follow-on Scemblix as Tasigna patent cliff nears

About two decades ago, Novartis transformed leukemia treatment with the introduction of Gleevec. Now, the Swiss pharma has ushered a third-generation therapy targeted...

2 November 2021 Regional News FDA | Gleevec

Continue Reading →

Regional News

Amid a push to resolve opioid and talc claims, Johnson & Johnson settles Risperdal litigation for $800M

Over the last few months, Johnson & Johnson has made sweeping moves to resolve a mountain of litigation involving the safety and marketing of its opioid and talc ...

2 November 2021 Regional News J&J | Johnson & Johnson

Continue Reading →

Regional News

Novo Nordisk casts Queen Latifah in TV-themed awareness campaign for obesity

Novo Nordisk takes a page from three popular TV genres—medical drama, '90s sitcom and procedural crime show—by casting actress Queen Latifah in a new video series awa...

2 November 2021 Regional News clinical | FDA

Continue Reading →

Regional News

AstraZeneca resumes asset sale in $270M COPD deal with familiar buyer Covis

Over the years, AstraZeneca has consistently adjusted its portfolio, targeting aging products. The company has now found a new home for two respiratory meds with an o...

2 November 2021 Regional News AstraZeneca | clinical trial

Continue Reading →

Regional News

Merck refiles $11.5B Acceleron deal with the FTC. But extending regulators’ review time only one benefit

Merck & Co.’s $11.5 billion bid for Acceleron Pharma is hitting a delay just as activist investors threaten to derail the deal altogether. Merck has withdrawn it...

2 November 2021 Regional News Acceleron Pharma | clinical research

Continue Reading →

Asia Pacific

SGS INCREASES BIOSAFETY TESTING CAPACITY AT ITS GLASGOW FACILITY

SGS has just completed a significant expansion project at its Glasgow facility, meaning it can provide increased biosafety testing for the biologics, drug development...

Continue Reading →